📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Connexin 43 is an independent predictor of patient outcome in breast cancer patients. (2019)

First Author: Chasampalioti M

Attributed to: Improving the functional affinity of human anti-glycan monoclonal antibodies (mabs) for cancer therapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s10549-018-5063-9

PubMed Identifier: 30474779

Publication URI: http://europepmc.org/abstract/MED/30474779

Type: Journal Article/Review

Volume: 174

Parent Publication: Breast cancer research and treatment

Issue: 1

ISSN: 0167-6806